-
Indian pharma industry best placed to play key role in global supply of hydroxychloroquine amid COVID-19 pandemic: GlobalData
expresspharma
April 14, 2020
Prashant Khadayate, Practice Head of Healthcare at GlobalData writes about out how India can supplement the acute need for hydroxychloroquine during the ongoing COVID-19 pandemic.
-
Over 280 units in SEZs operational to manufacture pharmaceuticals, hospital devices
expresspharma
April 08, 2020
Besides, more than 1,900 IT and IT-enable service units have been facilitated to enable their employees to work from home.
-
India to import PPE from China in COVID-19 fight, says report
europeanpharmaceuticalreview
April 07, 2020
New reports say that India will stock up on personal protective equipment and ventilators by banning exports and importing from China.
-
Takeda Appoints New Country Head for India
expresspharma
April 02, 2020
Koki Sato, a seasoned biopharmaceutical leader with over 17 years of experience across geographies has been assigned as the new lead of Takeda’s business in India.
-
High incident cases of invasive pneumococcal disease in India is result of lack of country-wide vaccination: GlobalData
expresspharma
April 02, 2020
Vaccination for pneumococcal disease was only introduced in children in late 2017 across three Indian states, and vaccination in the elderly is not a part of the national immunization program.
-
US urges India to lift export ban on pharmaceutical ingredients
pharmaceutical-technology
April 01, 2020
Officials of the US have asked India to lift the ban imposed on export of pharmaceutical ingredients amid the Covid-19 coronavirus pandemic.
-
DGFT defers track and trace deadline for pharma exports to October 1, 2020
expresspharma
April 01, 2020
The Directorate General of Foreign Trade (DGFT), an arm of the Ministry of Commerce and Industry, Government of India extended the deadline for implementation of the track ...
-
NPPA to ensure unobstructed movement of pharma related goods across India
expresspharma
March 30, 2020
Pharma industry along with retail chemists, wholesalers, pharma C&F agents of drugs and medicines and other members associated with the supply chain faces problem in the movement of goods, during initial days of nationwide lockdown.
-
Indian government ceases exports of Ipca (hydroxychloroquine)
europeanpharmaceuticalreview
March 27, 2020
India has stopped exporting the malaria drug Ipca (hydroxychloroquine), despite the FDA lifting its ban on imports due to its potential as a coronavirus treatment.
-
India to set up $1.3bn pharma manufacturing fund, says report
europeanpharmaceuticalreview
March 26, 2020
Due to the COVID-19 outbreak, India has decided to invest $1.3 billion into its internal drug manufacturing capabilities, says a new report.